Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;47(1):398-9.
doi: 10.1128/AAC.47.1.398-399.2003.

Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium

Affiliations

Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium

Brent W Gunderson et al. Antimicrob Agents Chemother. 2003 Jan.

Abstract

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium were exposed to linezolid (MIC of 2 mg/liter) under aerobic or anaerobic conditions in an in vitro pharmacodynamic model. Drug concentration and half-life were adjusted to simulate clinical dosing (600 mg twice daily) of linezolid. Linezolid produced a 2-log(10) killing at 24 h, and rates of killing against each of these facultative organisms as measured by mean survival time appeared similar under aerobic and anaerobic conditions.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Activities of linezolid against MRSA (A) and VREF (B) under aerobic (circles) and anaerobic (squares) conditions along with growth control (triangles).

Similar articles

Cited by

References

    1. Goldstein, E. J., D. M. Citron, and C. V. Merriam. 1999. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans. Antimicrob. Agents Chemother. 43:1469-1474. - PMC - PubMed
    1. Li, J., J. Turnidge, R. Milne, R. L. Nation, and K. Coulthard. 2001. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45:781-785. - PMC - PubMed
    1. Peterson, L. R., and D. N. Gerding. 1980. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev. Infect. Dis. 2:340-348. - PubMed
    1. Suller, M. T., and D. Lloyd. 2002. The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions. J. Appl. Microbiol. 92:866-872. - PubMed
    1. Zabinski, R. A., K. Vance-Bryan, A. J. Krinke, K. J. Walker, J. A. Moody, and J. C. Rotschafer. 1993. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. Antimicrob. Agents Chemother. 37:2454-2458. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources